Here’s what you need to know:
1. In their study, the researchers found a mutation that switched off a particular immune response hormone receptor. This mutation prevented mice from developing fibrosis, even after they were infected with a type of salmonella that mimics Crohn’s disease symptoms.
2. With this finding, the researchers believe they have identified the inflammatory cells that drive fibrosis.
3. Moving forward, the researchers will test drugs that may be able to block the hormone receptor. They will investigate whether these drugs can halt or reverse fibrosis in mice.
4. This research has implications for other fibrotic diseases, including liver cirrhosis, chronic kidney disease and scarring from heart attacks.
More articles on gastroenterology and endoscopy:
Hepatitis C-infected organs may prove safe transplants: 4 study insights
Endoscopic suturing effectively closes colonoscopy perforations: 5 study insights
Mount Sinai Hospital adopts Cellvizio System: 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
